Price
CHART BY
Historical dividends and forecast
Cryo-Cell Intl has so far distributed $0.40 in 2025. The next dividend will be paid on 28.02.2026
CHART BY
Frequently asked questions
What is Cryo-Cell Intl's market capitalization?
What is the Earnings Per Share (EPS) for Cryo-Cell Intl?
What are the analyst ratings and target price for Cryo-Cell Intl's stock?
What is Cryo-Cell Intl's revenue over the trailing twelve months?
What is the EBITDA for Cryo-Cell Intl?
What is the free cash flow of Cryo-Cell Intl?
How many employees does Cryo-Cell Intl have, and what sector and industry does it belong to?
What is the free float of Cryo-Cell Intl's shares?
Financials
- Market Cap
- $35.04M
- EPS (TTM)
- -$0.0592
- Free Float
- 3.82M
- Revenue (TTM)
- $31.75M
- EBITDA (TTM)
- $5.70M
- Free Cashflow (TTM)
- $6.18M
Pricing
- 1D span
- $4.258$4.495
- 52W span
- $4.11$9.38
Analyst Ratings
The price target is $8.50 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
- Employees
- 82
- Industries
- Other Transportation
- Sector
- Health Care
Identifier
- Primary Ticker
- CCEL
